Comments
Pharma major Dr Reddy’s Laboratories Ltd has launched Bivalirudin for injection.
It is the therapeutic equivalent generic version of Angiomax (Bivalirudin) for injection, approved by the US Food and Drug Administration (USFDA). Angiomax is a registered trademark of The Medicines Company.
The Angiomax brand and generic had US sales of approximately $198 million for the most recent 12 months ending March 2017, according to IMS Health,
Hyderabad-based Dr Reddy’s Bivalirudin injection is available in packages of 10 single-dose vials, according to a release.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.